Cross Country Healthcare Stock Forecast, Price & News

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cross Country Healthcare in the last twelve months. There are currently 1 sell rating, 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Cross Country Healthcare stock.
View analyst ratings for Cross Country Healthcare or view top-rated stocks.

Wall Street analysts have given Cross Country Healthcare a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Cross Country Healthcare wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Cross Country Healthcare saw a increase in short interest in August. As of August 31st, there was short interest totaling 731,300 shares, an increase of 23.2% from the August 15th total of 593,400 shares. Based on an average daily volume of 335,000 shares, the short-interest ratio is presently 2.2 days. Currently, 2.1% of the shares of the company are short sold.
View Cross Country Healthcare's Short Interest.

Cross Country Healthcare is scheduled to release its next quarterly earnings announcement on Wednesday, November 3rd 2021.
View our earnings forecast for Cross Country Healthcare.

Cross Country Healthcare, Inc. (NASDAQ:CCRN) released its quarterly earnings results on Wednesday, August, 4th. The business services provider reported $0.47 earnings per share for the quarter, beating analysts' consensus estimates of $0.40 by $0.07. The business services provider earned $331.83 million during the quarter, compared to analyst estimates of $306.21 million. Cross Country Healthcare had a trailing twelve-month return on equity of 30.00% and a net margin of 3.20%. The business's revenue was up 53.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.16 EPS.
View Cross Country Healthcare's earnings history.

Cross Country Healthcare's stock was trading at $7.84 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CCRN shares have increased by 166.3% and is now trading at $20.88.
View which stocks have been most impacted by COVID-19.

Cross Country Healthcare updated its third quarter 2021 earnings guidance on Wednesday, September, 1st. The company provided EPS guidance of $0.300-$0.350 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.220. The company issued revenue guidance of $310 million-$320 million, compared to the consensus revenue estimate of $253.33 million.

7 analysts have issued twelve-month price objectives for Cross Country Healthcare's stock. Their forecasts range from $7.50 to $23.00. On average, they expect Cross Country Healthcare's share price to reach $18.79 in the next twelve months. This suggests that the stock has a possible downside of 10.0%.
View analysts' price targets for Cross Country Healthcare or view top-rated stocks among Wall Street analysts.

34 employees have rated Cross Country Healthcare CEO Kevin Clark on Glassdoor.com. Kevin Clark has an approval rating of 73% among Cross Country Healthcare's employees.

Some companies that are related to Cross Country Healthcare include Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), R1 RCM (RCM), AMN Healthcare Services (AMN), Amedisys (AMED), LHC Group (LHCG), CorVel (CRVL), MEDNAX (MD) and Tivity Health (TVTY).
View all of CCRN's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cross Country Healthcare investors own include NVIDIA (NVDA), Energy Transfer (ET), OPKO Health (OPK), Enphase Energy (ENPH), Overstock.com (OSTK), QUALCOMM (QCOM), Vista Outdoor (VSTO), Twilio (TWLO), Advanced Micro Devices (AMD) and Activision Blizzard (ATVI).

Cross Country Healthcare trades on the NASDAQ under the ticker symbol "CCRN."

Cross Country Healthcare's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (15.01%), Vanguard Group Inc. (6.42%), Systematic Financial Management LP (6.40%), Aristotle Capital Boston LLC (5.46%), Dimensional Fund Advisors LP (4.58%) and State Street Corp (3.13%). Company insiders that own Cross Country Healthcare stock include Christopher R Pizzi, Colin Patrick Mcdonald, Daniele Addis, Joseph Trunfio, Kevin Cronin Clark, Stephen Alexis Saville, Susan E Ball, Thomas C Dircks, W Larry Cash and William J Burns.
View institutional ownership trends for Cross Country Healthcare.

CCRN stock was sold by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, JPMorgan Chase & Co., Aristotle Capital Boston LLC, Millennium Management LLC, Tocqueville Asset Management L.P., Russell Investments Group Ltd., BlackRock Inc., and Bank of America Corp DE. Company insiders that have sold Cross Country Healthcare company stock in the last year include Colin Patrick Mcdonald, Daniele Addis, Joseph Trunfio, and William J Burns.
View insider buying and selling activity for Cross Country Healthcare or view top insider-selling stocks.

CCRN stock was purchased by a variety of institutional investors in the last quarter, including Hillsdale Investment Management Inc., Systematic Financial Management LP, Invesco Ltd., Bridgeway Capital Management LLC, Renaissance Technologies LLC, Federated Hermes Inc., EAM Global Investors LLC, and Parametric Portfolio Associates LLC. Company insiders that have bought Cross Country Healthcare stock in the last two years include Joseph Trunfio, Kevin Cronin Clark, Stephen Alexis Saville, Susan E Ball, Thomas C Dircks, W Larry Cash, and William J Burns.
View insider buying and selling activity for Cross Country Healthcare or or view top insider-buying stocks.

Shares of CCRN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CCRN stock can currently be purchased for approximately $20.88.

Cross Country Healthcare has a market capitalization of $793.52 million and generates $836.42 million in revenue each year. The business services provider earns $-12,960,000.00 in net income (profit) each year or $0.46 on an earnings per share basis.

Cross Country Healthcare employs 7,487 workers across the globe.

Cross Country Healthcare was founded in 1996.

The official website for Cross Country Healthcare is www.crosscountryhealthcare.com.

Cross Country Healthcare is headquartered at 5201 CONGRESS AVENUE SUITE 100B, BOCA RATON FL, 33487.

Cross Country Healthcare's mailing address is 5201 CONGRESS AVENUE SUITE 100B, BOCA RATON FL, 33487. The business services provider can be reached via phone at (561) 998-2232 or via email at [email protected].